What You Should Know:
- Century Health has announced a strategic partnership with Datavant Connect—powered by AWS Clean Rooms—to bring AI-curated, disease-specific datasets directly to pharmaceutical and life sciences companies through a secure, no-data-movement platform.
- By joining Datavant’s Lighthouse Partner Program, Century Health enables researchers to discover and assess high-quality, longitudinal clinical data in minutes—not months—without accessing or transferring sensitive
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
NVIDIA Introduces La-Proteina: A Breakthrough in Atomistic Protein Generation via Partially Latent Flow Matching
What You Should Know:
- NVIDIA Research, in collaboration with the University of Oxford and Mila – Québec AI Institute, has unveiled La-Proteina, a novel method for atomistic protein design.
- Published on arXiv on July 13, 2025, La-Proteina is designed to directly generate fully atomistic protein structures jointly with their underlying amino acid sequences, addressing a critical challenge in de novo protein design.
Optimizing Protein Design with Fixed-Dimensional Latent
Read More
Ryght Partners w/ Emory Cancer Institute for AI-powered Clinical Trials
What You Should Know:
- Ryght AI, a provider of real-time generative AI healthcare technology for clinical research, today announced that the prestigious Winship Cancer Institute of Emory University has joined its unique Ryght Research Network.
- The global network creates an AI digital twin of every research site worldwide, allowing distinguished academic institutions like Winship to leverage Ryght's AI platform and applications to revolutionize clinical trial processes and
Read More
Personalis Expands Tempus AI Collaboration to Include Colorectal Cancer
What You Should Know:
- Personalis, Inc. announced a significant expansion and extension of its strategic collaboration with Tempus AI, Inc. that adds colorectal cancer (CRC) as a new indication to their existing, exclusive commercialization partnership.
- Personalis and Tempus will now work together to bring the NeXT Personal® ultra-sensitive, tumor-informed minimal residual disease (MRD) test to market for detecting cancer recurrence across four key areas: breast, lung, and
Read More
Centivax Raises $45M to Commercialize First Universal Flu Vaccine
What You Should Know:
- Centivax, a biotech company developing durable, universal vaccines, today announced the close of a $45 million Series A led by Steve Jurvetson’s Future Ventures, with participation from NFX, BOLD Capital, Base4, Kendall Capital Partners, Amplify Bio, and existing investors.
- The new funding will advance Centivax’s lead universal flu vaccine candidate through CMC development and into a Phase I trial within eight months.
Centivax Accelerates Universal Vaccine
Read More
Certara Expands Partnership with Merck to Streamline Drug Development Data Standards
What You Should Know:
- Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.
- The strategic agreement will see Merck increase its use of the Certara Pinnacle 21 software platform to include a metadata repository and data standards workflow management. This builds upon Merck’s existing technology collaboration with Certara aimed at aiding regulatory
Read More
The Future of MedTech Compliance: Why Dynamic Data is Transforming QARA
Technology advances are driving today's rapidly evolving medical device landscape and, as a result, traditional Quality Assurance and Regulatory Affairs (QARA) approaches are becoming increasingly obsolete. The industry is at a critical inflection point where static data management can no longer keep pace with the volume and complexity of global regulatory changes. This transformation is fermenting a fundamental shift toward dynamic data systems powered by artificial intelligence.
The
Read More
Catalio Capital Management Closes $400M+ Fund IV to Fuel Breakthrough Biomedical Innovation
What You Should Know:
- Catalio Capital Management, LP (“Catalio”), a healthcare investment firm, today announced the successful close of its fourth venture fund, Catalio Nexus Fund IV (“Fund IV”), with over $400M in commitments across the Fund and its related co-investment vehicles.
- Launched in 2020 by Co-Founders George Petrocheilos and Dr. Jacob Vogelstein, Catalio currently manages $2B in assets across its private equity, private credit, and public equities
Read More
LogicFlo AI Secures $2.7M to Optimize Life Sciences with AI Agent Workforce
What You Should Know:
- LogicFlo AI, a pioneering Boston-based startup, today announced it has secured $2.7M in seed funding led by Lightspeed with participation from healthcare and enterprise AI investors.
- The investment will accelerate the deployment of its intelligent agent platform across the pharmaceutical, biotech, and medtech industries. LogicFlo AI aims to free life sciences experts from tedious "busywork" by providing them with AI collaborators for high-stakes,
Read More
Verily and Vanderbilt Extend Partnership to Power NIH’s All of Us Researcher Workbench
What You Should Know:
- Verily and Vanderbilt University Medical Center (VUMC) today announced the continuation of their crucial partnership, ensuring the ongoing success and enhancement of the National Institutes of Health (NIH) All of Us Research Program’s Researcher Workbench platform.
- The extended 5-year collaboration reinforces Verily's role as a key technology partner, providing secure, cloud-based access to invaluable biomedical data for researchers worldwide.
A
Read More
